No data pointing to CYP-interaction. References consider it safe.

(To be edited, initial data ST OCT 04) Cholinesterase inhibitor of short duration used in intestinal and bladder atonia. Hydrolyzed by cholinesterases. No data pointing to CYP-metabolism. Australian list: safe EPI-list: use South African list: use

Uneventful use reported in 1 patient with acute porphyria.